 | Up a level |
Khadem Azarian, S. and Jafarnezhad-Ansariha, F. and Nazeri, S. and Azizi, G. and Aghazadeh, Z. and Hosseinzadeh, E. and Mirshafiey, A. (2020) Effects of guluronic acid, as a new NSAID with immunomodulatory properties on IL-17, RORγt, IL-4 and GATA-3 gene expression in rheumatoid arthritis patients. Immunopharmacology and Immunotoxicology, 42 (1). pp. 22-27.
Sharifi, L. and Mohsenzadegan, M. and Aghamohammadi, A. and Rezaei, N. and Zavareh, F.T. and Bokaie, S. and Moshiri, M. and Aghazadeh, Z. and Norouzbabaie, Z. and Azizi, G. and Mirshafiey, A. (2018) Immunomodulatory effect of G2013 (α-L-guluronic acid) on the TLR2 and TLR4 in human mononuclear cells. Current Drug Discovery Technologies, 15 (2). pp. 123-131.
Sharifi, L. and Mohsenzadegan, M. and Aghamohammadi, A. and Rezaei, N. and Zavareh, F.T. and Bokaie, S. and Moshiri, M. and Aghazadeh, Z. and Norouzbabaie, Z. and Azizi, G. and Mirshafiey, A. (2018) Immunomodulatory effect of G2013 (α-L-guluronic acid) on the TLR2 and TLR4 in human mononuclear cells. Current Drug Discovery Technologies, 15 (2). pp. 123-131.
